R
Robert Fagard
Researcher at Katholieke Universiteit Leuven
Publications - 788
Citations - 109235
Robert Fagard is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 114, co-authored 787 publications receiving 104613 citations.
Papers
More filters
Journal Article
Number of measurements required for the analysis of diurnal blood pressure profile
TL;DR: Investigation of how frequent blood pressure (BP) readings need to be obtained to reproduce the diurnal BP profile without loss or distortion of information found concordance tended to be better for the level of pressure than for the parameters of thediurnal profile.
Journal ArticleDOI
Blood pressure and urinary cations in urban bantu of zaire
TL;DR: In this urban Bantu population of Kinshasa, Zaïre, age and body weight are the major predictors of systolic pressure in youths and the major Predictors of both syStolic and diastolic Pressure in adults.
Journal ArticleDOI
Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies.
TL;DR: The present findings suggest that, in men, low serum levels of DHEAS may be associated with coronary heart disease, however, whether DHEA supplementation has any cardiovascular benefit is not clear.
Journal ArticleDOI
Comparison of cardiac output determined by a carbon dioxide-rebreathing and direct Fick method at rest and during exercise.
TL;DR: No systematic difference was shown between (a-v)CO2 content difference determined on whole blood and end-tidal gas, which justified the exclusion of a correction factor for blood to alveolar gas PCO2 gradients and in the calculation of cardiac output by the direct Fick method for CO2 and by CO2 rebreathing.
Journal Article
Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.
TL;DR: The SHEP trail did not demonstrate a significant beneficial effect of antihypertensive treatment on any of the cardiovascular mortality endpoints, and it is possible that due to selection, the SHEP patients were not entirely representative of the elderly with ISH in the population at large.